Interventional study with vitamin E in cardiovascular disease and meta-analysis

Area of Science:

• Biochemistry
• Cardiology
• Nutritional Science

Background:

• Cardiovascular disease (CVD) is a leading cause of death, with atherosclerosis being a primary underlying factor.
• Oxidative stress significantly contributes to the development and progression of atherosclerosis.
• Natural vitamin E, comprising tocopherols and tocotrienols, exhibits potent antioxidant and anti-inflammatory properties.

Purpose of the Study:

• To review the impact of vitamin E on the atherothrombotic process.
• To analyze experimental and clinical studies investigating vitamin E's role in cardiovascular health.
• To discuss the discrepancies between observational and interventional studies regarding vitamin E and CVD.

Main Methods:

• Literature review of experimental, in vitro, observational, and interventional studies.
• Analysis of vitamin E's antioxidant and anti-inflammatory mechanisms.
• Evaluation of clinical trial data on vitamin E supplementation and CVD outcomes.

Main Results:

• Vitamin E compounds are effective antioxidants and radical scavengers.
• Alpha-tocopherol demonstrates anti-inflammatory and anti-atherothrombotic effects by influencing platelet and clotting systems.
• Observational studies suggest an inverse relationship between vitamin E levels and CVD, but interventional trials show negative results.

Conclusions:

• Vitamin E possesses properties that target key mechanisms in atherothrombosis.
• Further research is needed to reconcile the conflicting results from different study designs.
• The role of vitamin E supplementation in CVD prevention requires careful consideration of trial design and outcomes.